S&P 500 · Health Care · USD · FY end 2025-12-31
Edwards Lifesciences (EW) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 6.07B | 1.07B | 1.83 | 1.34B |
| FY2024 | 5.44B | 4.17B | 6.97 | 289.90M |
| FY2023 | 6.00B | 1.40B | 2.30 | 642.80M |
| FY2022 | 5.38B | — | 2.44 | 973.60M |
| FY2021 | 5.23B | — | 2.38 | 1.41B |